Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth vs HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth |  HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment | |
|---|---|---|
| NAV | ₹17.579 | ₹22.3 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +21.86% | +25.46% |
| 3 year (p.a.) | +24.98% | +32.38% |
| 5 year (p.a.) | +24.98% | +32.38% |
| Expense ratio | 0.60% | 0.92% |
| Fund size | ₹664.02 Cr | ₹2362.44 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.